{"id":3412,"date":"2024-01-30T20:30:53","date_gmt":"2024-01-30T15:00:53","guid":{"rendered":"https:\/\/eliteayurveda.com\/blog\/?p=3412"},"modified":"2024-12-02T14:41:10","modified_gmt":"2024-12-02T09:11:10","slug":"6-indications-that-you-may-have-psoriasis","status":"publish","type":"post","link":"https:\/\/eliteayurveda.com\/blog\/6-indications-that-you-may-have-psoriasis\/","title":{"rendered":"6 indications that you may have psoriasis"},"content":{"rendered":"\n<p><strong>Indications That You May Have Psoriasis<\/strong><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><ul><li><a href=\"#what-is-psoriasis\">What Is Psoriasis?<\/a><\/li><li><a href=\"#key-indications-that-you-may-have-psoriasis\">Key Indications That You May Have Psoriasis<\/a><ul><li><a href=\"#1-red-scaly-patches-on-the-skin\">1. Red, Scaly Patches on the Skin<\/a><\/li><li><a href=\"#2-persistent-itching-or-burning-sensation\">2. Persistent Itching or Burning Sensation<\/a><\/li><li><a href=\"#3-dry-cracked-skin-that-bleeds-easily\">3. Dry, Cracked Skin That Bleeds Easily<\/a><\/li><li><a href=\"#4-changes-in-nails-nail-psoriasis\">4. Changes in Nails (Nail Psoriasis)<\/a><\/li><li><a href=\"#5-thick-crusty-plaques-on-the-scalp\">5. Thick, Crusty Plaques on the Scalp<\/a><\/li><li><a href=\"#6-small-drop-shaped-lesions-guttate-psoriasis\">6. Small, Drop-Shaped Lesions (Guttate Psoriasis)<\/a><\/li><li><a href=\"#7-joint-pain-and-stiffness-psoriatic-arthritis\">7. Joint Pain and Stiffness (Psoriatic Arthritis)<\/a><\/li><li><a href=\"#8-symptoms-that-worsen-with-triggers\">8. Symptoms That Worsen with Triggers<\/a><\/li><\/ul><\/li><li><a href=\"#types-of-psoriasis-and-their-specific-indications\">Types of Psoriasis and Their Specific Indications<\/a><ul><li><a href=\"#1-plaque-psoriasis\">1. Plaque Psoriasis<\/a><\/li><li><a href=\"#2-guttate-psoriasis\">2. Guttate Psoriasis<\/a><\/li><li><a href=\"#3-inverse-psoriasis\">3. Inverse Psoriasis<\/a><\/li><li><a href=\"#4-pustular-psoriasis\">4. Pustular Psoriasis<\/a><\/li><li><a href=\"#5-erythrodermic-psoriasis\">5. Erythrodermic Psoriasis<\/a><\/li><\/ul><\/li><li><a href=\"#why-early-diagnosis-matters\">Why Early Diagnosis Matters<\/a><ul><li><a href=\"#1-preventing-complications\">1. Preventing Complications<\/a><\/li><li><a href=\"#2-minimizing-emotional-impact\">2. Minimizing Emotional Impact<\/a><\/li><li><a href=\"#3-better-outcomes\">3. Better Outcomes<\/a><\/li><\/ul><\/li><li><a href=\"#ayurvedic-perspective-on-psoriasis\">Ayurvedic Perspective on Psoriasis<\/a><ul><li><a href=\"#ayurvedic-signs-of-psoriasis\">Ayurvedic Signs of Psoriasis<\/a><\/li><\/ul><\/li><li><a href=\"#how-elite-ayurveda-treats-psoriasis\">How EliteAyurveda Treats Psoriasis<\/a><ul><li><a href=\"#1-detoxification-shodhana\">1. Detoxification (Shodhana)<\/a><\/li><li><a href=\"#2-personalized-herbal-medications\">2. Personalized Herbal Medications<\/a><\/li><li><a href=\"#3-dietary-recommendations\">3. Dietary Recommendations<\/a><\/li><li><a href=\"#4-stress-management\">4. Stress Management<\/a><\/li><li><a href=\"#5-long-term-maintenance\">5. Long-Term Maintenance<\/a><\/li><\/ul><\/li><li><a href=\"#case-study-comprehensive-psoriasis-management\">Case Study: Comprehensive Psoriasis Management<\/a><\/li><li><a href=\"#from-the-doctors-desk-key-takeaways\">From the Doctor\u2019s Desk: Key Takeaways<\/a><\/li><li><a href=\"#conclusion\">Conclusion<\/a><\/li><li><a href=\"#references\">References<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<p><strong>Introduction<\/strong><\/p>\n\n\n\n<p>Psoriasis is a chronic autoimmune condition that primarily manifests on the skin but has systemic implications, affecting multiple aspects of health (Nestle, Kaplan, &amp; Barker, 2009). Characterized by thick, scaly patches, redness, and inflammation, psoriasis impacts an estimated 2\u20133% of the global population (Parisi et al., 2013). Despite its prevalence, many people go undiagnosed or misdiagnosed due to the variety of symptoms and their overlap with other skin conditions (Lebwohl, 2003).<\/p>\n\n\n\n<p>Understanding the early indications of psoriasis can help you seek timely medical intervention. Early diagnosis not only alleviates symptoms but also prevents potential complications such as psoriatic arthritis and cardiovascular diseases (Gelfand et al., 2006). At <strong>EliteAyurveda<\/strong>, we specialize in identifying and managing psoriasis through a personalized, root-cause approach, ensuring effective and sustainable results.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"529\" src=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-1024x529.webp\" alt=\"indications that you may have psoriasis\" class=\"wp-image-5067\" style=\"width:791px;height:auto\" srcset=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-1024x529.webp 1024w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-300x155.webp 300w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-768x397.webp 768w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-1536x793.webp 1536w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-2048x1058.webp 2048w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-696x359.webp 696w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-1068x552.webp 1068w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/Garima_Blog_Banner_53-813x420.webp 813w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">indications that you may have psoriasis<\/figcaption><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-is-psoriasis\"><strong>What Is Psoriasis?<\/strong><\/h3>\n\n\n\n<p>Psoriasis is an autoimmune condition where the immune system mistakenly attacks healthy skin cells, causing an accelerated cycle of skin cell turnover (Lowes, Su\u00e1rez-Fari\u00f1as, &amp; Krueger, 2014). This leads to a buildup of cells on the surface, forming the characteristic scaly patches or plaques. However, psoriasis is not limited to visible symptoms; it is a systemic disorder that can significantly impact physical, emotional, and mental health (Kimball et al., 2005).<\/p>\n\n\n\n<p>Research indicates that psoriasis is associated with several comorbidities, including metabolic syndrome, depression, and an increased risk of myocardial infarction (Gelfand et al., 2006). Therefore, recognizing the signs of psoriasis is crucial for comprehensive health management.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"key-indications-that-you-may-have-psoriasis\"><strong>Key Indications That You May Have Psoriasis<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-red-scaly-patches-on-the-skin\"><strong>1. Red, Scaly Patches on the Skin<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Appearance:<\/strong> Thickened, red areas of skin with silvery or white scales (Griffiths &amp; Barker, 2007).<\/li>\n\n\n\n<li><strong>Location:<\/strong> Commonly appears on elbows, knees, scalp, lower back, and sometimes on the hands and feet (National Psoriasis Foundation, n.d.).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> This is the hallmark symptom of plaque psoriasis, which accounts for approximately 80-90% of all psoriasis cases (Lowes et al., 2014).<\/li>\n<\/ul>\n\n\n\n<p>These patches result from the rapid proliferation of keratinocytes and inflammatory cell infiltration, leading to visible lesions (Nestle et al., 2009).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-persistent-itching-or-burning-sensation\"><strong>2. Persistent Itching or Burning Sensation<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Intense itching that is often accompanied by a burning or stinging sensation in the affected areas (Sch\u00e4fer, 2018).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Inflammation caused by psoriasis leads to nerve irritation, resulting in discomfort and a significant impact on quality of life (Kimball et al., 2005).<\/li>\n<\/ul>\n\n\n\n<p>Persistent itching can lead to scratching, which may exacerbate lesions and increase the risk of infection.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"3-dry-cracked-skin-that-bleeds-easily\"><strong>3. Dry, Cracked Skin That Bleeds Easily<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Skin that appears excessively dry, cracks easily, and bleeds after minor stretching or trauma (Langley, Krueger, &amp; Griffiths, 2005).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> The rapid cell turnover in psoriasis leads to an inability of the skin to retain moisture, increasing dryness and fragility (Lebwohl, 2003).<\/li>\n<\/ul>\n\n\n\n<p>Proper skin care and moisturization are essential to manage these symptoms and prevent secondary infections.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"4-changes-in-nails-nail-psoriasis\"><strong>4. Changes in Nails (Nail Psoriasis)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Pitting (small dents or depressions in the nails).<\/li>\n\n\n\n<li>Discoloration or yellowing of the nails.<\/li>\n\n\n\n<li>Nails lifting from the nail bed (<strong>onycholysis<\/strong>) (Armstrong et al., 2012).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Psoriasis commonly affects nails, occurring in up to 50% of patients, especially in individuals with psoriatic arthritis (Gladman et al., 2005).<\/li>\n<\/ul>\n\n\n\n<p>Nail psoriasis can be an early indicator of psoriatic arthritis, making timely recognition crucial.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"5-thick-crusty-plaques-on-the-scalp\"><strong>5. Thick, Crusty Plaques on the Scalp<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Flaky or scaly buildup on the scalp that may extend to the hairline, neck, or behind the ears (Van de Kerkhof, 2015).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Scalp psoriasis, a subtype of psoriasis, is often mistaken for severe dandruff but is more persistent and inflammatory (National Psoriasis Foundation, n.d.).<\/li>\n<\/ul>\n\n\n\n<p>Scalp involvement occurs in approximately 50-80% of patients and can lead to social embarrassment and psychological distress (Kimball et al., 2005).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"6-small-drop-shaped-lesions-guttate-psoriasis\"><strong>6. Small, Drop-Shaped Lesions (Guttate Psoriasis)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Red, teardrop-shaped spots appearing on the trunk, arms, legs, or scalp (Tobin &amp; Kirby, 2005).<\/li>\n\n\n\n<li><strong>Trigger:<\/strong> Often follows a bacterial or viral infection, such as strep throat (Gudjonsson &amp; Elder, 2007).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Guttate psoriasis is more common in younger individuals and can be a precursor to chronic plaque psoriasis.<\/li>\n<\/ul>\n\n\n\n<p>Prompt treatment of the triggering infection can improve skin symptoms.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"7-joint-pain-and-stiffness-psoriatic-arthritis\"><strong>7. Joint Pain and Stiffness (Psoriatic Arthritis)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Pain, swelling, and stiffness in the joints, particularly in the morning or after periods of inactivity (Gladman et al., 2005).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Around 30% of psoriasis patients develop psoriatic arthritis, which can cause permanent joint damage if untreated (Mease, 2011).<\/li>\n<\/ul>\n\n\n\n<p>Early diagnosis and intervention are critical to prevent joint destruction and maintain function.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"8-symptoms-that-worsen-with-triggers\"><strong>8. Symptoms That Worsen with Triggers<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>What to Look For:<\/strong> Flare-ups triggered by stress, cold weather, certain foods, infections, or medications (Fortune et al., 2002).<\/li>\n\n\n\n<li><strong>What It Means:<\/strong> Psoriasis symptoms are exacerbated by external and internal stressors, reflecting the inflammatory nature of the condition.<\/li>\n<\/ul>\n\n\n\n<p>Identifying and managing triggers is a key component of effective psoriasis management.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"types-of-psoriasis-and-their-specific-indications\"><strong>Types of Psoriasis and Their Specific Indications<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-plaque-psoriasis\"><strong>1. Plaque Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptoms:<\/strong> Thick, scaly patches on the skin with redness and inflammation (Lowes et al., 2014).<\/li>\n\n\n\n<li><strong>Affected Areas:<\/strong> Elbows, knees, lower back, and scalp.<\/li>\n<\/ul>\n\n\n\n<p>This is the most common form of psoriasis and is characterized by well-defined plaques that can coalesce to cover large areas of skin.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-guttate-psoriasis\"><strong>2. Guttate Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptoms:<\/strong> Small, drop-like red spots on the skin (Tobin &amp; Kirby, 2005).<\/li>\n\n\n\n<li><strong>Trigger:<\/strong> Often follows infections such as strep throat.<\/li>\n<\/ul>\n\n\n\n<p>Guttate psoriasis may resolve spontaneously or develop into chronic plaque psoriasis.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"3-inverse-psoriasis\"><strong>3. Inverse Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptoms:<\/strong> Smooth, shiny, red lesions in skin folds (e.g., under breasts, groin, buttocks) (Kumar et al., 2013).<\/li>\n\n\n\n<li><strong>Trigger:<\/strong> Aggravated by sweat and friction.<\/li>\n<\/ul>\n\n\n\n<p>This type is prone to fungal infections due to the moist environment in skin folds.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"4-pustular-psoriasis\"><strong>4. Pustular Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptoms:<\/strong> White pustules surrounded by red, inflamed skin (Mrowietz &amp; Van De Kerkhof, 2011).<\/li>\n\n\n\n<li><strong>Trigger:<\/strong> May be caused by withdrawal from certain medications or overexposure to UV light.<\/li>\n<\/ul>\n\n\n\n<p>Pustular psoriasis can be localized or generalized and requires immediate medical attention due to its severity.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"5-erythrodermic-psoriasis\"><strong>5. Erythrodermic Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptoms:<\/strong> Severe redness, peeling, and shedding of the skin over large areas (Menter et al., 2009).<\/li>\n\n\n\n<li><strong>Trigger:<\/strong> This severe form can result from untreated or poorly managed psoriasis.<\/li>\n<\/ul>\n\n\n\n<p>Erythrodermic psoriasis is life-threatening and requires urgent medical care.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"why-early-diagnosis-matters\"><strong>Why Early Diagnosis Matters<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-preventing-complications\"><strong>1. Preventing Complications<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Psoriatic Arthritis:<\/strong> Early intervention can prevent joint damage and disability (Mease, 2011).<\/li>\n\n\n\n<li><strong>Comorbidities:<\/strong> Reduces the risk of developing cardiovascular disease, diabetes, and metabolic syndrome (Gelfand et al., 2006).<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-minimizing-emotional-impact\"><strong>2. Minimizing Emotional Impact<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mental Health:<\/strong> Timely diagnosis and treatment reduce the stigma and psychological burden associated with visible skin lesions (Kimball et al., 2005).<\/li>\n\n\n\n<li><strong>Quality of Life:<\/strong> Improves self-esteem and social interactions.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"3-better-outcomes\"><strong>3. Better Outcomes<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Disease Management:<\/strong> Managing psoriasis at its early stages leads to fewer flare-ups and prolonged remission (Menter et al., 2009).<\/li>\n\n\n\n<li><strong>Treatment Efficacy:<\/strong> Early treatment may respond better and prevent disease progression.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ayurvedic-perspective-on-psoriasis\"><strong>Ayurvedic Perspective on Psoriasis<\/strong><\/h3>\n\n\n\n<p>In Ayurveda, psoriasis is viewed as a manifestation of imbalances in the <strong>Pitta<\/strong> (fire) and <strong>Kapha<\/strong> (earth and water) doshas, compounded by toxin buildup (<strong>Ama<\/strong>) in the body (Sharma et al., 2007). These imbalances disrupt the body&#8217;s natural harmony, leading to skin inflammation, dryness, and scaling.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"ayurvedic-signs-of-psoriasis\"><strong>Ayurvedic Signs of Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Excessive Heat in the Body (Pitta Imbalance):<\/strong> Results in inflammation and redness.<\/li>\n\n\n\n<li><strong>Dryness and Flaking (Vata Aggravation):<\/strong> Leads to scaling and itching.<\/li>\n\n\n\n<li><strong>Toxin Accumulation (Ama Buildup):<\/strong> Due to poor digestion and metabolic waste, exacerbating symptoms (Mukherjee &amp; Wahile, 2006).<\/li>\n<\/ul>\n\n\n\n<p>Ayurveda emphasizes treating the root cause by restoring doshic balance and eliminating toxins through detoxification and lifestyle modifications.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"how-elite-ayurveda-treats-psoriasis\"><strong>How EliteAyurveda Treats Psoriasis<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-detoxification-shodhana\"><strong>1. Detoxification (Shodhana)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Process:<\/strong> Cleansing therapies like Panchakarma remove toxins and purify the blood, reducing systemic inflammation (Pandey &amp; Chandola, 2013).<\/li>\n\n\n\n<li><strong>Benefit:<\/strong> Enhances the body&#8217;s natural healing processes and prepares it for rejuvenation.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-personalized-herbal-medications\"><strong>2. Personalized Herbal Medications<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Formulations:<\/strong> Tailored herbal preparations balance doshas, support immunity, and improve skin health (Mukherjee &amp; Wahile, 2006).<\/li>\n\n\n\n<li><strong>Examples:<\/strong> Neem (<em>Azadirachta indica<\/em>) for detoxification, Turmeric (<em>Curcuma longa<\/em>) for anti-inflammatory effects.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"3-dietary-recommendations\"><strong>3. Dietary Recommendations<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Foods to Include:<\/strong> Cooling, anti-inflammatory foods like cucumbers, leafy greens, and coconut water to pacify Pitta (Lad, 2002).<\/li>\n\n\n\n<li><strong>Foods to Avoid:<\/strong> Spicy, oily, and processed foods that aggravate Pitta and Kapha.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"4-stress-management\"><strong>4. Stress Management<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Techniques:<\/strong> Incorporating mindfulness, yoga, and breathing exercises to mitigate stress-induced flare-ups (Sharma et al., 2007).<\/li>\n\n\n\n<li><strong>Benefit:<\/strong> Reduces cortisol levels, promoting hormonal balance and immune regulation.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"5-long-term-maintenance\"><strong>5. Long-Term Maintenance<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lifestyle Changes:<\/strong> Adopting daily routines (<strong>Dinacharya<\/strong>) and seasonal regimens (<strong>Ritucharya<\/strong>) to maintain doshic balance (Frawley, 2000).<\/li>\n\n\n\n<li><strong>Follow-Up:<\/strong> Regular consultations to adjust treatments as needed for sustained remission.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"case-study-comprehensive-psoriasis-management\"><strong>Case Study: Comprehensive Psoriasis Management<\/strong><\/h3>\n\n\n\n<p><strong>Patient Profile:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Age:<\/strong> 42<\/li>\n\n\n\n<li><strong>Symptoms:<\/strong> Severe plaque psoriasis with recurring scalp lesions and joint stiffness.<\/li>\n\n\n\n<li><strong>Triggers:<\/strong> High stress and a diet rich in processed foods.<\/li>\n<\/ul>\n\n\n\n<p><strong>Treatment Plan:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Detoxification:<\/strong> Weekly external Ayurvedic therapies, including <em>Abhyanga<\/em> (oil massage) and <em>Swedana<\/em> (herbal steam therapy), and internal herbal detox drinks (Pandey &amp; Chandola, 2013).<\/li>\n\n\n\n<li><strong>Personalized Medications:<\/strong> Herbal formulations containing Neem and Turmeric to balance Pitta and strengthen immunity (Mukherjee &amp; Wahile, 2006).<\/li>\n\n\n\n<li><strong>Dietary Adjustments:<\/strong> Incorporation of cooling foods such as cucumbers, fresh greens, and coconut water; elimination of spicy and processed foods (Lad, 2002).<\/li>\n\n\n\n<li><strong>Stress Management:<\/strong> Daily yoga practices and meditation sessions to reduce flare-ups (Sharma et al., 2007).<\/li>\n<\/ol>\n\n\n\n<p><strong>Outcome:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>4 Weeks:<\/strong> Visible improvement in skin lesions; reduced itching and scaling.<\/li>\n\n\n\n<li><strong>3 Months:<\/strong> Significant reduction in joint stiffness and inflammation; improved mobility.<\/li>\n\n\n\n<li><strong>1 Year:<\/strong> Sustained remission with adherence to Ayurvedic principles; enhanced quality of life.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"from-the-doctors-desk-key-takeaways\"><strong>From the Doctor\u2019s Desk: Key Takeaways<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Recognize Symptoms Early:<\/strong> Early identification of psoriasis symptoms can prevent complications like psoriatic arthritis and improve treatment outcomes (Mease, 2011).<\/li>\n\n\n\n<li><strong>Holistic Treatment Matters:<\/strong> A personalized Ayurvedic approach addresses the root causes, ensuring long-term remission and overall well-being (Sharma et al., 2007).<\/li>\n\n\n\n<li><strong>Commit to Lifestyle Changes:<\/strong> Consistent adherence to Ayurvedic principles, including diet and stress management, leads to sustainable relief and prevents recurrence (Frawley, 2000).<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"conclusion\"><strong>Conclusion<\/strong><\/h3>\n\n\n\n<p>Psoriasis is more than just a skin condition\u2014it is a systemic disorder with potential long-term consequences if left untreated (Gelfand et al., 2006). Recognizing the early signs and seeking holistic care can help manage symptoms effectively and improve quality of life. At <strong>EliteAyurveda<\/strong>, our personalized treatments combine ancient Ayurvedic wisdom with modern insights to deliver sustainable, transformative results.<\/p>\n\n\n\n<p><strong>Ready to take control of your psoriasis?<\/strong> \ud83d\udcde <strong>Contact us at +91 8884722246<\/strong> \ud83c\udf10 <strong>Visit our website: <a href=\"https:\/\/www.eliteayurveda.com\/\">www.eliteayurveda.com<\/a><\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Related-<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/www.eliteayurveda.com\/diseases\/skin\/psoriasis\/\" target=\"_blank\" rel=\"noreferrer noopener\">Know More About Ayurveda Treatment For Psoriasis<\/a><\/p>\n\n\n\n<div class=\"wp-block-group alignfull has-text-color has-background\" style=\"color:#000000;background-color:#ffffff\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>GET IN TOUCH<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong><a href=\"https:\/\/www.eliteayurveda.com\/contact-us\/\" target=\"_blank\" rel=\"noreferrer noopener\">Schedule a Visit<\/a><\/strong><\/h2>\n\n\n\n<div class=\"wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-499968f5 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background wp-element-button\" href=\"https:\/\/www.eliteayurveda.com\/contact-us\/\" style=\"border-radius:50px;color:#ffffff;background-color:#000000\" target=\"_blank\" rel=\"noreferrer noopener\">Contact us<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"references\"><strong>References<\/strong><\/h3>\n\n\n\n<p>1.Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, Paul CF, Puig L, Reich K, van de Kerkhof PC. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(5):871\u2013881.e871\u2013830. doi: 10.1016\/j.jaad.2013.12.018.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2013.12.018\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24576585\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Patient%20perspectives%20in%20the%20management%20of%20psoriasis:%20results%20from%20the%20population-based%20Multinational%20Assessment%20of%20Psoriasis%20and%20Psoriatic%20Arthritis%20Survey&amp;author=MG%20Lebwohl&amp;author=H%20Bachelez&amp;author=J%20Barker&amp;author=G%20Girolomoni&amp;author=A%20Kavanaugh&amp;volume=70&amp;issue=5&amp;publication_year=2014&amp;pages=871-881.e871%E2%80%93830&amp;pmid=24576585&amp;doi=10.1016\/j.jaad.2013.12.018&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>2.Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512\u2013516. doi: 10.1016\/j.jaad.2013.11.013.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2013.11.013\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24388724\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Psoriasis%20prevalence%20among%20adults%20in%20the%20United%20States&amp;author=TD%20Rachakonda&amp;author=CW%20Schupp&amp;author=AW%20Armstrong&amp;volume=70&amp;issue=3&amp;publication_year=2014&amp;pages=512-516&amp;pmid=24388724&amp;doi=10.1016\/j.jaad.2013.11.013&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>3.Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377\u2013385. doi: 10.1038\/jid.2012.339.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/jid.2012.339\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23014338\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Invest%20Dermatol&amp;title=Global%20epidemiology%20of%20psoriasis:%20a%20systematic%20review%20of%20incidence%20and%20prevalence&amp;author=R%20Parisi&amp;author=DP%20Symmons&amp;author=CE%20Griffiths&amp;author=DM%20Ashcroft&amp;volume=133&amp;issue=2&amp;publication_year=2013&amp;pages=377-385&amp;pmid=23014338&amp;doi=10.1038\/jid.2012.339&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>4.Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450\u2013456. doi: 10.1016\/S0190-9622(85)70188-0.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/S0190-9622(85)70188-0\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/4056119\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Psoriasis%20of%20early%20and%20late%20onset:%20characterization%20of%20two%20types%20of%20psoriasis%20vulgaris&amp;author=T%20Henseler&amp;author=E%20Christophers&amp;volume=13&amp;issue=3&amp;publication_year=1985&amp;pages=450-456&amp;pmid=4056119&amp;doi=10.1016\/S0190-9622(85)70188-0&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>5.Andressen C, Henseler T [Inheritance of psoriasis. Analysis of 2035 family histories]. Hautarzt. 1982;33(4):214\u20137.\u00a0[<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7096085\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>]<\/p>\n\n\n\n<p>6.Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826\u2013850. doi: 10.1016\/j.jaad.2008.02.039.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2008.02.039\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18423260\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Guidelines%20of%20care%20for%20the%20management%20of%20psoriasis%20and%20psoriatic%20arthritis:%20Section%201.%20Overview%20of%20psoriasis%20and%20guidelines%20of%20care%20for%20the%20treatment%20of%20psoriasis%20with%20biologics&amp;author=A%20Menter&amp;author=A%20Gottlieb&amp;author=SR%20Feldman&amp;author=AS%20van%20Voorhees&amp;author=CL%20Leonardi&amp;volume=58&amp;issue=5&amp;publication_year=2008&amp;pages=826-850&amp;pmid=18423260&amp;doi=10.1016\/j.jaad.2008.02.039&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>7.Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280\u2013284.\u00a0[<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11255325\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch%20Dermatol&amp;title=The%20impact%20of%20psoriasis%20on%20quality%20of%20life:%20results%20of%20a%201998%20National%20Psoriasis%20Foundation%20patient-membership%20survey&amp;author=G%20Krueger&amp;author=J%20Koo&amp;author=M%20Lebwohl&amp;author=A%20Menter&amp;author=RS%20Stern&amp;volume=137&amp;issue=3&amp;publication_year=2001&amp;pages=280-284&amp;pmid=11255325&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>8.Pariser D, Schenkel B, Carter C, Farahi K, Brown TM, Ellis CN. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatolog Treat. 2016;27(1):19\u201326. doi: 10.3109\/09546634.2015.1044492.\u00a0[<a href=\"https:\/\/doi.org\/10.3109\/09546634.2015.1044492\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4732424\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26138406\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Dermatolog%20Treat&amp;title=A%20multicenter,%20non-interventional%20study%20to%20evaluate%20patient-reported%20experiences%20of%20living%20with%20psoriasis&amp;author=D%20Pariser&amp;author=B%20Schenkel&amp;author=C%20Carter&amp;author=K%20Farahi&amp;author=TM%20Brown&amp;volume=27&amp;issue=1&amp;publication_year=2016&amp;pages=19-26&amp;pmid=26138406&amp;doi=10.3109\/09546634.2015.1044492&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>9.Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401\u2013407. doi: 10.1016\/S0190-9622(99)70112-X.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/S0190-9622(99)70112-X\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10459113\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Psoriasis%20causes%20as%20much%20disability%20as%20other%20major%20medical%20diseases&amp;author=SR%20Rapp&amp;author=SR%20Feldman&amp;author=ML%20Exum&amp;author=AB%20Fleischer&amp;author=DM%20Reboussin&amp;volume=41&amp;issue=3%20Pt%201&amp;publication_year=1999&amp;pages=401-407&amp;pmid=10459113&amp;doi=10.1016\/S0190-9622(99)70112-X&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>10.Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS. US perspectives in the Management of Psoriasis and Psoriatic Arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Am J Clin Dermatol. 2016;17:87\u201397. doi: 10.1007\/s40257-015-0169-x.\u00a0[<a href=\"https:\/\/doi.org\/10.1007\/s40257-015-0169-x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4733141\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26718712\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20J%20Clin%20Dermatol&amp;title=US%20perspectives%20in%20the%20Management%20of%20Psoriasis%20and%20Psoriatic%20Arthritis:%20patient%20and%20physician%20results%20from%20the%20population-based%20multinational%20assessment%20of%20psoriasis%20and%20psoriatic%20arthritis%20(MAPP)%20survey&amp;author=MG%20Lebwohl&amp;author=A%20Kavanaugh&amp;author=AW%20Armstrong&amp;author=AS%20Van%20Voorhees&amp;volume=17&amp;publication_year=2016&amp;pages=87-97&amp;pmid=26718712&amp;doi=10.1007\/s40257-015-0169-x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>11.Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JYM, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851\u2013864. doi: 10.1016\/j.jaad.2008.02.040.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2008.02.040\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18423261\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Guidelines%20of%20care%20for%20the%20management%20of%20psoriasis%20and%20psoriatic%20arthritis:%20Section%202.%20Psoriatic%20arthritis:%20overview%20and%20guidelines%20of%20care%20for%20treatment%20with%20an%20emphasis%20on%20the%20biologics&amp;author=A%20Gottlieb&amp;author=NJ%20Korman&amp;author=KB%20Gordon&amp;author=SR%20Feldman&amp;author=M%20Lebwohl&amp;volume=58&amp;issue=5&amp;publication_year=2008&amp;pages=851-864&amp;pmid=18423261&amp;doi=10.1016\/j.jaad.2008.02.040&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>12.Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321\u2013328. doi: 10.1007\/s00403-006-0703-z.\u00a0[<a href=\"https:\/\/doi.org\/10.1007\/s00403-006-0703-z\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17021763\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch%20Dermatol%20Res&amp;title=Increased%20prevalence%20of%20the%20metabolic%20syndrome%20in%20patients%20with%20moderate%20to%20severe%20psoriasis&amp;author=DM%20Sommer&amp;author=S%20Jenisch&amp;author=M%20Suchan&amp;author=E%20Christophers&amp;author=M%20Weichenthal&amp;volume=298&amp;issue=7&amp;publication_year=2006&amp;pages=321-328&amp;pmid=17021763&amp;doi=10.1007\/s00403-006-0703-z&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>13.Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527\u20131534. doi: 10.1001\/archderm.141.12.1527.\u00a0[<a href=\"https:\/\/doi.org\/10.1001\/archderm.141.12.1527\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16365253\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch%20Dermatol&amp;title=Impact%20of%20obesity%20and%20smoking%20on%20psoriasis%20presentation%20and%20management&amp;author=MD%20Herron&amp;author=M%20Hinckley&amp;author=MS%20Hoffman&amp;author=J%20Papenfuss&amp;author=CB%20Hansen&amp;volume=141&amp;issue=12&amp;publication_year=2005&amp;pages=1527-1534&amp;pmid=16365253&amp;doi=10.1001\/archderm.141.12.1527&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>14.Higgins Alcohol, smoking and psoriasis. Clin Exp Dermatol. 2000;25(2):107\u2013110. doi: 10.1046\/j.1365-2230.2000.00588.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1046\/j.1365-2230.2000.00588.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10733631\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Clin%20Exp%20Dermatol&amp;title=Alcohol,%20smoking%20and%20psoriasis&amp;volume=25&amp;issue=2&amp;publication_year=2000&amp;pages=107-110&amp;pmid=10733631&amp;doi=10.1046\/j.1365-2230.2000.00588.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>15.Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. RIsk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735\u20131741. doi: 10.1001\/jama.296.14.1735.\u00a0[<a href=\"https:\/\/doi.org\/10.1001\/jama.296.14.1735\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17032986\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=JAMA&amp;title=RIsk%20of%20myocardial%20infarction%20in%20patients%20with%20psoriasis&amp;author=JM%20Gelfand&amp;author=AL%20Neimann&amp;author=DB%20Shin&amp;author=X%20Wang&amp;author=DJ%20Margolis&amp;volume=296&amp;issue=14&amp;publication_year=2006&amp;pages=1735-1741&amp;pmid=17032986&amp;doi=10.1001\/jama.296.14.1735&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>16.Mallbris L, Akre O, Granath F, Yin L, Lindel\u00f6f B, Ekbom A, St\u00e5hle-B\u00e4ckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19(3):225\u2013230. doi: 10.1023\/B:EJEP.0000020447.59150.f9.\u00a0[<a href=\"https:\/\/doi.org\/10.1023\/B:EJEP.0000020447.59150.f9\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15117115\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Eur%20J%20Epidemiol&amp;title=Increased%20risk%20for%20cardiovascular%20mortality%20in%20psoriasis%20inpatients%20but%20not%20in%20outpatients&amp;author=L%20Mallbris&amp;author=O%20Akre&amp;author=F%20Granath&amp;author=L%20Yin&amp;author=B%20Lindel%C3%B6f&amp;volume=19&amp;issue=3&amp;publication_year=2004&amp;pages=225-230&amp;pmid=15117115&amp;doi=10.1023\/B:EJEP.0000020447.59150.f9&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>17.Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. The Lancet. 2007;370(9583):263\u2013271. doi: 10.1016\/S0140-6736(07)61128-3.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(07)61128-3\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17658397\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=The%20Lancet&amp;title=Pathogenesis%20and%20clinical%20features%20of%20psoriasis&amp;author=CEM%20Griffiths&amp;author=JNWN%20Barker&amp;volume=370&amp;issue=9583&amp;publication_year=2007&amp;pages=263-271&amp;pmid=17658397&amp;doi=10.1016\/S0140-6736(07)61128-3&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>18.Sheu J-J, Wang K-H, Lin H-C, Huang C-C. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol. 2013;68(6):992\u2013999. doi: 10.1016\/j.jaad.2012.12.961.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2012.12.961\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23374233\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Psoriasis%20is%20associated%20with%20an%20increased%20risk%20of%20parkinsonism:%20a%20population-based%205-year%20follow-up%20study&amp;author=J-J%20Sheu&amp;author=K-H%20Wang&amp;author=H-C%20Lin&amp;author=C-C%20Huang&amp;volume=68&amp;issue=6&amp;publication_year=2013&amp;pages=992-999&amp;pmid=23374233&amp;doi=10.1016\/j.jaad.2012.12.961&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>19.Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11\u201327. doi: 10.1007\/s00281-015-0539-8.\u00a0[<a href=\"https:\/\/doi.org\/10.1007\/s00281-015-0539-8\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4706579\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26573299\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Semin%20Immunopathol&amp;title=Update%20on%20psoriasis%20immunopathogenesis%20and%20targeted%20immunotherapy&amp;author=SK%20Mahil&amp;author=F%20Capon&amp;author=JN%20Barker&amp;volume=38&amp;issue=1&amp;publication_year=2016&amp;pages=11-27&amp;pmid=26573299&amp;doi=10.1007\/s00281-015-0539-8&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>20.Basavaraj KH, Ashok NM, Rashmi R, Praveen TK. The role of drugs in the induction and\/or exacerbation of psoriasis. Int J Dermatol. 2010;49(12):1351\u20131361. doi: 10.1111\/j.1365-4632.2010.04570.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04570.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21091671\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Int%20J%20Dermatol&amp;title=The%20role%20of%20drugs%20in%20the%20induction%20and\/or%20exacerbation%20of%20psoriasis&amp;author=KH%20Basavaraj&amp;author=NM%20Ashok&amp;author=R%20Rashmi&amp;author=TK%20Praveen&amp;volume=49&amp;issue=12&amp;publication_year=2010&amp;pages=1351-1361&amp;pmid=21091671&amp;doi=10.1111\/j.1365-4632.2010.04570.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>21.Gilleaudeau P, Vallat VP, Carter DM, Gottlieb AB. Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis. J Am Acad Dermatol. 1993;28(3):490\u2013492. doi: 10.1016\/S0190-9622(08)81761-6.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/S0190-9622(08)81761-6\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8267693\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Angiotensin-converting%20enzyme%20inhibitors%20as%20possible%20exacerbating%20drugs%20in%20psoriasis&amp;author=P%20Gilleaudeau&amp;author=VP%20Vallat&amp;author=DM%20Carter&amp;author=AB%20Gottlieb&amp;volume=28&amp;issue=3&amp;publication_year=1993&amp;pages=490-492&amp;pmid=8267693&amp;doi=10.1016\/S0190-9622(08)81761-6&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>22.Marquart-Elbaz C, Grosshans E, Lipsker D, Lipsker D. Sartans, angiotensin II receptor antagonists, can induce psoriasis. Br J Dermatol. 2002;147(3):617\u2013618. doi: 10.1046\/j.1365-2133.2002.48848.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1046\/j.1365-2133.2002.48848.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12207619\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Br%20J%20Dermatol&amp;title=Sartans,%20angiotensin%20II%20receptor%20antagonists,%20can%20induce%20psoriasis&amp;author=C%20Marquart-Elbaz&amp;author=E%20Grosshans&amp;author=D%20Lipsker&amp;author=D%20Lipsker&amp;volume=147&amp;issue=3&amp;publication_year=2002&amp;pages=617-618&amp;pmid=12207619&amp;doi=10.1046\/j.1365-2133.2002.48848.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>23.Brauchli YB, Jick SS, Curtin F, Meier CR. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol. 2008;158(6):1299\u20131307. doi: 10.1111\/j.1365-2133.2008.08563.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08563.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18410416\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Br%20J%20Dermatol&amp;title=Association%20between%20beta-blockers,%20other%20antihypertensive%20drugs%20and%20psoriasis:%20population-based%20case-control%20study&amp;author=YB%20Brauchli&amp;author=SS%20Jick&amp;author=F%20Curtin&amp;author=CR%20Meier&amp;volume=158&amp;issue=6&amp;publication_year=2008&amp;pages=1299-1307&amp;pmid=18410416&amp;doi=10.1111\/j.1365-2133.2008.08563.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>24.Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg. 2016;33(3):355\u2013366. doi: 10.1016\/j.cpm.2016.02.004.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.cpm.2016.02.004\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27215156\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Clin%20Podiatr%20Med%20Surg&amp;title=Psoriasis:%20pathogenesis,%20assessment,%20and%20therapeutic%20update&amp;author=SM%20Schleicher&amp;volume=33&amp;issue=3&amp;publication_year=2016&amp;pages=355-366&amp;pmid=27215156&amp;doi=10.1016\/j.cpm.2016.02.004&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>25.Asumalahti K, Ameen M, Suomela S, Hagforsen E, Micha\u00eblsson G, Evans J, Munro M, Veal C, Allen M, Leman J, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Investig Dermatol. 2003;120(4):627\u2013632. doi: 10.1046\/j.1523-1747.2003.12094.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12094.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12648227\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Investig%20Dermatol&amp;title=Genetic%20analysis%20of%20PSORS1%20distinguishes%20guttate%20psoriasis%20and%20palmoplantar%20pustulosis&amp;author=K%20Asumalahti&amp;author=M%20Ameen&amp;author=S%20Suomela&amp;author=E%20Hagforsen&amp;author=G%20Micha%C3%ABlsson&amp;volume=120&amp;issue=4&amp;publication_year=2003&amp;pages=627-632&amp;pmid=12648227&amp;doi=10.1046\/j.1523-1747.2003.12094.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>26.Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NVC, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78(5):827\u2013851. doi: 10.1086\/503821.\u00a0[<a href=\"https:\/\/doi.org\/10.1086\/503821\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1474031\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16642438\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Sequence%20and%20haplotype%20analysis%20supports%20HLA-C%20as%20the%20psoriasis%20susceptibility%201%20gene&amp;author=RP%20Nair&amp;author=PE%20Stuart&amp;author=I%20Nistor&amp;author=R%20Hiremagalore&amp;author=NVC%20Chia&amp;volume=78&amp;issue=5&amp;publication_year=2006&amp;pages=827-851&amp;pmid=16642438&amp;doi=10.1086\/503821&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>27.Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;24(8):15392. doi: 10.1038\/ncomms15382.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/ncomms15382\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5458077\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28537254\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Nat%20Commun&amp;title=Large%20scale%20meta-analysis%20characterizes%20genetic%20architecture%20for%20common%20psoriasis%20associated%20variants&amp;author=LC%20Tsoi&amp;author=PE%20Stuart&amp;author=C%20Tian&amp;author=JE%20Gudjonsson&amp;author=S%20Das&amp;volume=24&amp;issue=8&amp;publication_year=2017&amp;pages=15392&amp;pmid=28537254&amp;doi=10.1038\/ncomms15382&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>28.Elder JT, Bruce AT, Gudjonsson JE, Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR, Nair RP. Molecular dissection of psoriasis: integrating genetics and biology. J Investig Dermatol. 2010;130(5):1213\u20131226. doi: 10.1038\/jid.2009.319.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/jid.2009.319\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19812592\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Investig%20Dermatol&amp;title=Molecular%20dissection%20of%20psoriasis:%20integrating%20genetics%20and%20biology&amp;author=JT%20Elder&amp;author=AT%20Bruce&amp;author=JE%20Gudjonsson&amp;author=A%20Johnston&amp;author=PE%20Stuart&amp;volume=130&amp;issue=5&amp;publication_year=2010&amp;pages=1213-1226&amp;pmid=19812592&amp;doi=10.1038\/jid.2009.319&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>29.Eberle Franziska C., Br\u00fcck J\u00fcrgen, Holstein Julia, Hirahara Kiyoshi, Ghoreschi Kamran. Recent advances in understanding psoriasis. F1000Research. 2016;5:770. doi: 10.12688\/f1000research.7927.1.\u00a0[<a href=\"https:\/\/doi.org\/10.12688\/f1000research.7927.1\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4850872\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27158469\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=F1000Research&amp;title=Recent%20advances%20in%20understanding%20psoriasis&amp;author=Franziska%20C.%20Eberle&amp;author=J%C3%BCrgen%20Br%C3%BCck&amp;author=Julia%20Holstein&amp;author=Kiyoshi%20Hirahara&amp;author=Kamran%20Ghoreschi&amp;volume=5&amp;publication_year=2016&amp;pages=770&amp;pmid=27158469&amp;doi=10.12688\/f1000research.7927.1&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>30.Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015;33(1):13\u201323. doi: 10.1016\/j.det.2014.09.002.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.det.2014.09.002\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25412780\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Dermatol%20Clin&amp;title=The%20immunopathogenesis%20of%20psoriasis&amp;author=J%20Kim&amp;author=JG%20Krueger&amp;volume=33&amp;issue=1&amp;publication_year=2015&amp;pages=13-23&amp;pmid=25412780&amp;doi=10.1016\/j.det.2014.09.002&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>31.Fredriksson T, Pettersson U. Severe psoriasis\u2014oral therapy with a new retinoid. Dermatology. 1978;157(4):238\u2013244. doi: 10.1159\/000250839.\u00a0[<a href=\"https:\/\/doi.org\/10.1159\/000250839\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/357213\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Dermatology&amp;title=Severe%20psoriasis%E2%80%94oral%20therapy%20with%20a%20new%20retinoid&amp;author=T%20Fredriksson&amp;author=U%20Pettersson&amp;volume=157&amp;issue=4&amp;publication_year=1978&amp;pages=238-244&amp;pmid=357213&amp;doi=10.1159\/000250839&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>32.Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician&#8217;s global assessment. J Am Acad Dermatol. 2004;51(4):563\u2013569. doi: 10.1016\/j.jaad.2004.04.012.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2004.04.012\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15389191\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Evaluating%20psoriasis%20with%20psoriasis%20area%20and%20severity%20index,%20psoriasis%20global%20assessment,%20and%20lattice%20system%20physician%27s%20global%20assessment&amp;author=RG%20Langley&amp;author=CN%20Ellis&amp;volume=51&amp;issue=4&amp;publication_year=2004&amp;pages=563-569&amp;pmid=15389191&amp;doi=10.1016\/j.jaad.2004.04.012&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>33.Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509. doi: 10.1056\/NEJMra0804595.\u00a0[<a href=\"https:\/\/doi.org\/10.1056\/NEJMra0804595\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19641206\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Psoriasis&amp;author=FO%20Nestle&amp;author=DH%20Kaplan&amp;author=J%20Barker&amp;volume=361&amp;issue=5&amp;publication_year=2009&amp;pages=496-509&amp;pmid=19641206&amp;doi=10.1056\/NEJMra0804595&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>34.Raposo I, Torres T. Palmoplantar psoriasis and palmoplantar pustulosis: current treatment and future prospects. Am J Clin Dermatol. 2016;17(4):349\u2013358. doi: 10.1007\/s40257-016-0191-7.\u00a0[<a href=\"https:\/\/doi.org\/10.1007\/s40257-016-0191-7\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27113059\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20J%20Clin%20Dermatol&amp;title=Palmoplantar%20psoriasis%20and%20palmoplantar%20pustulosis:%20current%20treatment%20and%20future%20prospects&amp;author=I%20Raposo&amp;author=T%20Torres&amp;volume=17&amp;issue=4&amp;publication_year=2016&amp;pages=349-358&amp;pmid=27113059&amp;doi=10.1007\/s40257-016-0191-7&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>35.Lisi P. Differential diagnosis of psoriasis. Reumatismo. 2007;59(Suppl 1):56\u201360.\u00a0[<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17828346\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Reumatismo&amp;title=Differential%20diagnosis%20of%20psoriasis&amp;author=P%20Lisi&amp;volume=59&amp;issue=Suppl%201&amp;publication_year=2007&amp;pages=56-60&amp;pmid=17828346&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>36.Martin BA, Chalmers RG, Telfer NR. HOw great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol. 1996;132(6):717\u2013718. doi: 10.1001\/archderm.1996.03890300147032.\u00a0[<a href=\"https:\/\/doi.org\/10.1001\/archderm.1996.03890300147032\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8651734\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch%20Dermatol&amp;title=HOw%20great%20is%20the%20risk%20of%20further%20psoriasis%20following%20a%20single%20episode%20of%20acute%20guttate%20psoriasis?&amp;author=BA%20Martin&amp;author=RG%20Chalmers&amp;author=NR%20Telfer&amp;volume=132&amp;issue=6&amp;publication_year=1996&amp;pages=717-718&amp;pmid=8651734&amp;doi=10.1001\/archderm.1996.03890300147032&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>37.Varman KM, Namias N, Schulman CI, Pizano LR. Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit. A review of clinical features and new therapeutics. Burns. 2014;40(4):e35\u2013e39. doi: 10.1016\/j.burns.2014.01.003.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.burns.2014.01.003\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24491419\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Burns&amp;title=Acute%20generalized%20pustular%20psoriasis,%20von%20Zumbusch%20type,%20treated%20in%20the%20burn%20unit.%20A%20review%20of%20clinical%20features%20and%20new%20therapeutics&amp;author=KM%20Varman&amp;author=N%20Namias&amp;author=CI%20Schulman&amp;author=LR%20Pizano&amp;volume=40&amp;issue=4&amp;publication_year=2014&amp;pages=e35-e39&amp;pmid=24491419&amp;doi=10.1016\/j.burns.2014.01.003&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>38.Matsubara M, Komori M, Koishi K, Yasuno H, Ueda K, Seto Y, Nonomura K. Generalized pustular psoriasis and bacteremia. J Dermatol. 1983;10(6):525\u2013529. doi: 10.1111\/j.1346-8138.1983.tb01176.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1346-8138.1983.tb01176.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/6368631\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Dermatol&amp;title=Generalized%20pustular%20psoriasis%20and%20bacteremia&amp;author=M%20Matsubara&amp;author=M%20Komori&amp;author=K%20Koishi&amp;author=H%20Yasuno&amp;author=K%20Ueda&amp;volume=10&amp;issue=6&amp;publication_year=1983&amp;pages=525-529&amp;pmid=6368631&amp;doi=10.1111\/j.1346-8138.1983.tb01176.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>39.Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16(6):669\u2013673.\u00a0[<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17229609\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Eur%20J%20Dermatol&amp;title=Generalized%20pustular%20psoriasis%20(Zumbusch):%20a%20French%20epidemiological%20survey&amp;author=F%20Augey&amp;author=P%20Renaudier&amp;author=JF%20Nicolas&amp;volume=16&amp;issue=6&amp;publication_year=2006&amp;pages=669-673&amp;pmid=17229609&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indications That You May Have Psoriasis Introduction Psoriasis is a chronic autoimmune condition that primarily manifests on the skin but has systemic implications, affecting multiple aspects of health (Nestle, Kaplan, &amp; Barker, 2009). Characterized by thick, scaly patches, redness, and inflammation, psoriasis impacts an estimated 2\u20133% of the global population (Parisi et al., 2013). Despite [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3413,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-3412","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-general"},"_links":{"self":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/comments?post=3412"}],"version-history":[{"count":3,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3412\/revisions"}],"predecessor-version":[{"id":5068,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3412\/revisions\/5068"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media\/3413"}],"wp:attachment":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media?parent=3412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/categories?post=3412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/tags?post=3412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}